These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16641457)

  • 61. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.
    Darouiche RO; Mansouri MD; Gawande PV; Madhyastha S
    J Antimicrob Chemother; 2009 Jul; 64(1):88-93. PubMed ID: 19447791
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel synergistic antibiofilm combinations for salvage of infected catheters.
    Venkatesh M; Rong L; Raad I; Versalovic J
    J Med Microbiol; 2009 Jul; 58(Pt 7):936-944. PubMed ID: 19502361
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antimicrobial peptides as potential tool to fight bacterial biofilm.
    Dawgul M; Maciejewska M; Jaskiewicz M; Karafova A; Kamysz W
    Acta Pol Pharm; 2014; 71(1):39-47. PubMed ID: 24779193
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An antimicrobial modified silicone peritoneal catheter with activity against both Gram-positive and Gram-negative bacteria.
    Bayston R; Fisher LE; Weber K
    Biomaterials; 2009 Jun; 30(18):3167-73. PubMed ID: 19289248
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fibrinogen Deposition on Silicone Oil-Infused Silver-Releasing Urinary Catheters Compromises Antibiofilm and Anti-Encrustation Properties.
    Zhang S; Teng X; Liang X; Gadd GM; McCoy CP; Dong Y; Wang Y; Zhao Q
    Langmuir; 2023 Jan; 39(4):1562-1572. PubMed ID: 36661856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.
    Curtin JJ; Donlan RM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1268-75. PubMed ID: 16569839
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synergistic activity of weak organic acids against uropathogens.
    Burns J; McCoy CP; Irwin NJ
    J Hosp Infect; 2021 May; 111():78-88. PubMed ID: 33545217
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
    Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
    East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro efficacy of antimicrobial-coated bladder catheters in inhibiting bacterial migration along catheter surface.
    Darouiche RO; Safar H; Raad II
    J Infect Dis; 1997 Oct; 176(4):1109-12. PubMed ID: 9333179
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Catheter-associated urinary tract infections: new aspects of novel urinary catheters.
    Ha US; Cho YH
    Int J Antimicrob Agents; 2006 Dec; 28(6):485-90. PubMed ID: 17045784
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections.
    Strempel N; Strehmel J; Overhage J
    Curr Pharm Des; 2015; 21(1):67-84. PubMed ID: 25189860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.
    Chauhan A; Lebeaux D; Ghigo JM; Beloin C
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6310-8. PubMed ID: 23027191
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extraction and quantification of biofilm bacteria: Method optimized for urinary catheters.
    Mandakhalikar KD; Rahmat JN; Chiong E; Neoh KG; Shen L; Tambyah PA
    Sci Rep; 2018 May; 8(1):8069. PubMed ID: 29795121
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biofilm formation by clinical isolates and the implications in chronic infections.
    Sanchez CJ; Mende K; Beckius ML; Akers KS; Romano DR; Wenke JC; Murray CK
    BMC Infect Dis; 2013 Jan; 13():47. PubMed ID: 23356488
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activity of a nitrofurazone matrix urinary catheter against catheter-associated uropathogens.
    Johnson JR; Berggren T; Conway AJ
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2033-6. PubMed ID: 8239629
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Light insensitive silver(I) cyanoximates as antimicrobial agents for indwelling medical devices.
    Gerasimchuk N; Gamian A; Glover G; Szponar B
    Inorg Chem; 2010 Nov; 49(21):9863-74. PubMed ID: 20873734
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.